CLINICAL TRIAL WITH CYCLOPENTIMINE
Abstract
A clinical trial was conducted on 30 hospitalized female patients with cyclopentimine. Decreasing aggressiveness and euphoria were observed as beneficial effects in 8 patients.
However, because of the uncontrollable side effects of severe nausea, vomiting, loss of weight and insomnia, as well as extrapyramidal symptoms, headache and allergic dermatitis, the trial had to be discontinued prematurely.
It seems that these severe side effects at the present time overshadow the compound's potential therapeutic value.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
